Home
Browse
Prime browse
Clustered VIS browse
Search
Curation
Gene
Target gene
All
Oncogene
Tumor suppressor gene
Nearby gene
All
Oncogene
Tumor suppressor gene
MicroRNA
RNA-interaction
ncRNA
Host2Host
Host2Virus
Virus2Host
• miRNA
Host2Host
Host2Virus
Virus2Host
• lncRNA
Host2Host
Host2Virus
Virus2Host
Download
Statistics
Help
VISDB
Viral Integration Site DataBase
Homepage
Prime VIS Browse Options
TVIS10018585
Proximate region of VIS (GRCh38)
VIS
Enhancer
Enhancer/Promoter
Promoter
Gene
35777010
35718019
35738878
35704527
35717038
35666516
35678483
35710199
35720186
35667948
35673291
35701801
35703400
35672719
35673821
35689923
35690318
35693859
35694048
35696979
35697128
35721763
Expression analysis of TCGA samples
Basic Information
VIS ID
TVIS10018585
Fusion event
HBV-KMT2B integration
Validated
No
Detection method
VirusFinder
Data source
Curated
Sample type
Tumor
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Reported year
2017
PubMed ID
29212479
Virus Sequence
Virus name
HBV
Reference genome
NC_003977
Start
1955
Integrated sequence
GTCCTACTGTTCAAGCCTCCAAGCTGTGCCTTGGGTGGCTTTGGGGCATGGACATCGACCCTTATAAAGAATTTGGAGCTACTGTGGAGTTACTCTCGTT| |TTTGCCTTCTGACTTCTTTCCTTCAGTACGAGATCTTCTAGATACCGCCTCAGCTCTGTATCGGGAAGCCTTAGAGTCTCCTGAGCATTGTTCACCTCAC
Host Sequence
Chromosome
chr19
Cytoband
q13.12
Reference genome
GRCh37.55
Start
36212665/35721763 (Hg38)
End
36212665/35721763 (Hg38)
Location type
Exon3
Fragile sites / regions
FRA19A
Target gene
KMT2B
miRNAs that regulate target gene
hsa-mir-7515
;
hsa-mir-302a-5p
;
hsa-mir-3154
;
hsa-mir-6782-3p
;
hsa-mir-519c-3p
;
hsa-mir-519b-3p
;
hsa-mir-519a-3p
;
hsa-mir-5692a
;
hsa-mir-548t-5p
;
hsa-mir-548az-5p
;
hsa-mir-526b-3p
;
hsa-mir-519d-3p
;
hsa-mir-93-5p
;
hsa-mir-20a-5p
;
hsa-mir-17-5p
;
hsa-mir-106b-5p
;
hsa-mir-106a-5p
;
hsa-mir-20b-5p
;
hsa-mir-153-3p
;
hsa-mir-1224-3p
;
hsa-mir-1294
;
hsa-mir-1914-3p
;
hsa-mir-214-3p
;
hsa-mir-31-5p
;
hsa-mir-3184-5p
;
hsa-mir-3619-5p
;
hsa-mir-3689d
;
hsa-mir-423-5p
;
hsa-mir-4316
;
hsa-mir-4426
;
hsa-mir-4440
;
hsa-mir-4459
;
hsa-mir-4647
;
hsa-mir-4662b
;
hsa-mir-4688
;
hsa-mir-4722-5p
;
hsa-mir-5194
;
hsa-mir-6085
;
hsa-mir-6165
;
hsa-mir-6734-5p
;
hsa-mir-6738-5p
;
hsa-mir-6743-5p
;
hsa-mir-6789-5p
;
hsa-mir-6813-5p
;
hsa-mir-6851-5p
;
hsa-mir-761
;
hsa-mir-7704
;
hsa-mir-885-3p
Nearest miRNA
hsa-mir-10395/Upstream/376136; hsa-let-7e/Downstream/3687860;
Nearest TSS
ENST00000633603/Upstream/861;
ENST00000592092/Downstream/11495;
Nearest CpG islands
None/Target,
chr19-CpG: 112/Upstream/1739
,
chr19-CpG: 24/Downstream/1963
Upstream sequence
CAGGCAGCAGAATATAGTGGTTATAGGAACACAGGTGGAAACCCTGTCCAAAGCAAGGGCTATCGGGTATCACCTCTGACCATCCTTCCCATTCATCCTC
Downstream sequence
TCGATCAGCAGCAGCAGCAGAAGGTGGCAGCTTCCATGCCGGTGAGTGTGGTCCCTGGGCCCAGCGGCACACCCAGCCATCCAGCCTCCATTCTTTGCAA
Reference
Yoo, S., et al. A pilot systematic genomic comparison of recurrence risks of hepatitis B virus-associated hepatocellular carcinoma with low- and high-degree liver fibrosis. BMC Med ,2017, 15(1): 214.
Sample Information
×
Sample name
P161A
Sample type
Tumor
Gender
Female
CpG Island Information
×
Download
Curate